-
Do nothing but observe microprolactinomas: when and how to replace sex hormones? Pituitary. 2020 Jun; 23(3):307-313.
Bonert V. PMID: 32274622.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study. Pituitary. 2018 Feb; 21(1):65-75.
Bonert V, Carmichael J, Wu Z, Mirocha J, Perez DA, Clarke NJ, Reitz RE, McPhaul MJ, Mamelak A. PMID: 29218459.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Diagnostic challenges in acromegaly: a case-based review. Best Pract Res Clin Endocrinol Metab. 2009 Dec; 23 Suppl 1:S23-30.
Bonert V. PMID: 20129191.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Is long-acting repeatable octreotide an effective primary therapy for patients with acromegaly? Nat Clin Pract Endocrinol Metab. 2008 Jan; 4(1):18-9.
Bonert VS. PMID: 17955038.
View in:
PubMed Mentions: Fields:
-
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet. 2001 Nov 24; 358(9295):1754-9.
van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO. PMID: 11734231.
View in:
PubMed Mentions:
127 Fields:
Translation:
HumansCTClinical Trials
-
Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma. J Clin Endocrinol Metab. 2000 Sep; 85(9):3409-16.
Maheshwari HG, Prezant TR, Herman-Bonert V, Shahinian H, Kovacs K, Melmed S. PMID: 10999842.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansCells
-
Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs. J Clin Endocrinol Metab. 2000 Aug; 85(8):2958-61.
Herman-Bonert VS, Zib K, Scarlett JA, Melmed S. PMID: 10946911.
View in:
PubMed Mentions:
21 Fields:
Translation:
HumansCTClinical Trials
-
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med. 2000 Apr 20; 342(16):1171-7.
Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ. PMID: 10770982.
View in:
PubMed Mentions:
164 Fields:
Translation:
HumansCTClinical Trials
-
Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab. 2000 Jan; 85(1):168-74.
Drange MR, Fram NR, Herman-Bonert V, Melmed S. PMID: 10634382.
View in:
PubMed Mentions:
45 Fields:
Translation:
Humans
-
Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab. 1998 Mar; 83(3):727-31.
Herman-Bonert V, Seliverstov M, Melmed S. PMID: 9506716.
View in:
PubMed Mentions:
18 Fields:
Translation:
Humans
-
Molecular pathogenesis of pituitary tumours. Baillieres Clin Endocrinol Metab. 1995 Apr; 9(2):203-23.
Herman-Bonert V, Fagin JA. PMID: 7625983.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansAnimalsCells
-
Gonadotropin secretory abnormalities. Endocrinol Metab Clin North Am. 1991 Sep; 20(3):519-38.
Herman-Bonert VS, Braunstein GD. PMID: 1935919.
View in:
PubMed Mentions: Fields:
Translation:
Humans